Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS)

R. Salvini, I. Passadore, A. M. Bardoni, E. Pozzi, A. M. Fietta, F. Meloni (Pavia, Italy)

Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Session: Dealing with chronic allograft dysfunction: mission impossible?
Session type: Oral Presentation
Number: 776

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Salvini, I. Passadore, A. M. Bardoni, E. Pozzi, A. M. Fietta, F. Meloni (Pavia, Italy). Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS). Eur Respir J 2006; 28: Suppl. 50, 776

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cryptogenic organising pneumonia - COP
Source: Respipedia Article
Year: 2016

The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020




Ten–years longitudinal study of lung function parameters and elastase activity in lavage fluid in young patients with chronic bronchiolitis obliterans (CBO)
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009


Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004

IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 465s
Year: 2004

Inflammatory markers in serum and lavage fluid in young adult’s patients with postinfectious bronchiolitis obliterans
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013

Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013


Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011


Aberrant metalloprotease expression and activity in bronchoalveolar lavage fluid of bronchiolitis obliterans patients
Source: Annual Congress 2013 –New insights into mechanisms of lung allograft dysfunction
Year: 2013


Lung clearance index (LCI) as a sensitive marker of post-transplant bronchiolitis obliterans syndrome (BOS)
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018

Phenotype of lung lymphocytes in bronchial asthma and chronic bronchitis patients in bronchial (BLF) and alveolar (ALF) lavage fluids
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001

Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018


Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

Pulmonary circulation changes in children with bronchiolitis obliterans (BO)
Source: Eur Respir J 2005; 26: Suppl. 49, 29s
Year: 2005

The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014